HaluGen is a subsidiary of Entheon Biomedical that provides DNA testing services to evaluate a persons overall sensitivity and risk profile when using psychedelic drugs. The company claims that their home-test kit can predict a ‘bad trip’ based on a persons genetic profile. Given that no studies have taken place proving the efficacy of the kit, the exact science remains speculative at best. In June 2021 HaluGen’s testing became available to consumers in the US.
News
- At-Home Genetic Testing Can’t Tell You If You’re Going to Have a Bad Trip (Vice, August 2021)
Activities
B2C
Digital Health / Software / App
Biotech
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates